Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.

Yip-Schneider MT, Wu H, Stantz K, Agaram N, Crooks PA, Schmidt CM. Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer. BMC Cancer. 2013 Apr 17; 13:194.

View in: PubMed

subject areas

Adenocarcinoma
Animals
Antineoplastic Combined Chemotherapy Protocols
Cytokines
Deoxycytidine
Disease Models, Animal
Immunohistochemistry
Mice
Mice, Mutant Strains
NF-kappa B
Pancreatic Neoplasms
Sesquiterpenes

authors with profiles

Peter Crooks